These stocks made huge moves in today's session 📈

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Welcome to the Closing Bell Roundup. Please, feel free to reply to this email and tell us what you think of this new addition to the Elite Trade Club lineup! It's Tuesday, October 18th. I hope you had a great day! Here's what moved the market today: Markets 📈 US indexes pulled back after a strong open, but still managed to close the trading session with solid gains. The S&P 500 [+1.1%], Dow [+1.1%], Nasdaq [+0.9%], and Russell 2K [+1.0%] all closed the day with gains. Sthttps:// 200elitetra.de/JO7z Sponsored [Wall Street Legend Warns “Financial Reset” is Coming]( A historic event in 2023 could soon result in a run on the banks. Get out of cash and into this new asset vehicle... It's been 50 years in the making, and it could be the opportunity of a lifetime. [MORE HERE]( Today's Market-Moving News 🔎 - Microsoft Lay-Offs: The tech giant laid off more employees this week, possibly hinting that the company has concerns about future demand. - EU Seeks Emergency Price Cap: European Union officials want to impose an emergency price cap on natural gas prices in the bloc's primary trading exchange as part of an effort to shield consumers from soaring prices. Today's Top Winners and Losers 🔥 Agrify Corp [AGFY] $4.43 (-58.6%) Today, Agrify announced a 1-for-10 reverse stock split would take effect at midnight tonight in an effort to maintain compliance with Nasdaq Capital Market's minimum bid price requirements, prompting a selloff in shares. Salarious Pharmaceuticals Inc [SLRX] $2.7411 (-45.1%) Salrius Pharma voluntarily paused enrollment in a Phase 1/2 trial of seclidemstat in cancer patients due to a "patient death that was classified as a suspected unexpected serious adverse reaction," according to a company statement. Inpixon [INPX ://elitetra.de/L2Ic ] $5.13 (-43.6%) Inpixon said today it has entered into an agreement to sell about $15 million worth of its common stock and warrants to a single institutional investor at a price of $5.85 per unit, and shares plummeted on the news. The company agreed to sell roughly 2.56 million shares and warrants for another 3.84 million shares as part of the deal. Akouos Inc [AKUS] $13.18 (+87.9%) Eli Lilly [ELI +0.6%] has agreed to acquire Akouos in a $610 million cash tender deal that will pay shareholders $12.50 per share at closing. The deal also includes terms that will allow shareholders to receive an additional $3 in cash dependent on the outcome of certain drug trials. Quoin Pharmaceuticals Ltd [QNRX] $2.73 (+44.4%) Quoin Pharma soared after announcing plans to initiate a second clinical trial of QRX003 topical lotion in Netherton Syndrome patients who are receiving treatments. The study will be performed under a New Drug Application and will investigate numerous clinical endpoints. AVEO Pharmaceuticals Inc [AVEO] $14.92 (+42.3%) AVEO soared on news that LG Chem agreed to acquire the company in an all-cash deal worth $566 million that will pay shareholders $15 per share. Shares were up 38.8% as of this morning's report, but they closed ever higher after rallying throughout the trading session. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( alerts delivered straight to your cell every morning for free?* P.P.S... Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! You can also text CLOSE to 47121 to get the Closing Bell Roundup sent to your mobile inbox, too! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](